Unified AEMS platform gives consumers real‑time safety data and replaces seven costly legacy systems.
WASHINGTON, DC — The U.S. Food and Drug Administration has launched the Adverse Event Monitoring System (AEMS), a unified, real‑time platform that replaces seven aging databases used to track safety reports across FDA‑regulated products. The agency says the modernization will save $120 million over five years and give the public faster access to critical safety information.
AEMS consolidates roughly 6 million reports per year into a single dashboard, replacing systems that were costly, fragmented, and difficult to search. Commissioner Marty Makary, M.D., M.P.H., said the overhaul eliminates blind spots in postmarket surveillance and gives agency scientists and the public a clearer view of potential safety patterns.
The platform currently displays reports for drugs, biologics, vaccines, cosmetics, and animal food. By May 2026, medical devices, human foods, dietary supplements, and tobacco products will also be processed in AEMS. Historical data from legacy systems will be migrated as they are decommissioned.
Chief AI Officer Jeremy Walsh called the transition the largest technical modernization in FDA history.
What This Means for Consumers
For the general public, AEMS delivers real‑time visibility into safety reports for everyday products—medications, vaccines, cosmetics, supplements, pet food, and soon medical devices and tobacco products. Instead of navigating multiple government databases or waiting months for updates, consumers can now search one dashboard and see new reports as they are filed.
The unified system also strengthens the FDA’s ability to detect early safety patterns, helping the agency respond more quickly when clusters of adverse events emerge. And because AEMS replaces several expensive legacy systems, the modernization reduces long‑term federal costs while improving transparency.
Systems now integrated
– FAERS — drugs, biologics, cosmetics, color additives
– VAERS — vaccines (co‑managed with CDC; displayed in AEMS)
– AERS — animal drugs and animal foods
Systems joining in May
– MAUDE — medical devices
– HFCS — human foods and dietary supplements
– CTPAE — tobacco and ENDS products
Consumer inquiries: 888‑INFO‑FDA
© 2026 BCDollarSaver.com. All rights reserved.
Be the first to comment